Quarterly Results

  • Company Name :
Zydus Lifesciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532321
  • NSE Symbol:
  • ZYDUSLIFE
  • P/E(TTM):
  • 19.76
  • ISIN Demat:
  • INE010B01027
  • Div & Yield%:
  • 1.19
  • EPS(TTM):
  • 46.69
  • Book Value(₹):
  • 215.08
  • Market Cap(₹Cr.):
  • 92,825.09
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 2,207.20 2,808.80 2,495.80
Excise Duty 0.00 0.00 0.00
Net Sales 2,207.20 2,808.80 2,495.80
Other Operating Income 76.40 62.40 92.50
Other Income 473.80 541.50 157.10
Total Income 2,757.40 3,412.70 2,745.40
Total Expenditure 2,144.70 1,719.30 2,002.90
PBIDT 612.70 1,693.40 742.50
Interest 116.00 113.80 137.60
PBDT 496.70 1,579.60 604.90
Depreciation 144.30 136.00 130.00
Tax 81.80 281.70 89.60
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -25.90 5.30 0.60
Reported Profit After Tax 296.50 1,156.60 384.70
Extra-ordinary Items -46.15 0.00 0.00
Adjusted Profit After Extra-ordinary item 342.65 1,156.60 384.70
EPS (Unit Curr.) 2.95 11.49 3.82
EPS (Adj) (Unit Curr.) 2.95 11.49 3.82
Calculated EPS (Unit Curr.) 2.95 11.50 3.82
Calculated EPS (Adj) (Unit Curr.) 2.95 11.50 3.82
Calculated EPS (Ann.) (Unit Curr.) 11.79 45.99 15.30
Calculated EPS (Adj) (Ann.) (Unit Curr.) 11.79 45.99 15.30
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 100.60 100.60 100.60
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 27.76 60.29 29.75
PBDTM(%) 22.50 56.24 24.24
PATM(%) 13.43 41.18 15.41